Review and analysis of 2023 Clinical Guidelines for Lipid Metabolism Disorders

QR Code

Review and analysis of 2023 Clinical Guidelines for Lipid Metabolism Disorders

The novelty of the 2023 National Guidelines for Lipid Metabolism Disorders is presented regarding the categorization of cardiovascular risk, target and optimal levels of blood lipids, diagnosis and therapeutic approaches to the treatment of dyslipidemia.

Saved in:

Bibliographic Details
Main Authors:	I. V. Sergienko, M. V. Ezhov
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2023-12-01
Series:	Российский кардиологический журнал
Subjects:	lipid metabolism disorders dyslipidemia atherosclerosis low-density lipoprotein cholesterol triglycerides lipoprotein(a) inclisiran fenofibrate
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/5688
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Disorders of lipid metabolism. Clinical Guidelines 2023
by: M. V. Ezhov, et al.
Published: (2023-06-01)

Eurasian Association of Cardiology (EAC)/ Russian National Atherosclerosis Society (RNAS) Guidelines for the diagnosis and correction of dyslipidemia for the prevention and treatment of atherosclerosis (2025)
by: M. V. Ezhov, et al.
Published: (2025-06-01)

Dyslipidemia in the Russian Federation: population data, associations with risk factors
by: O. M. Drapkina, et al.
Published: (2023-12-01)

Effect of aqueous extract of olive (Olea europaea) fruit on lipid profile in female rabbits
by: Baghdad Science Journal
Published: (2010-12-01)

2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk
by: Francois Mach, et al.
Published: (2020-06-01)

Associations of changes in lipid metabolism parameters and the severity of COVID-19 infection in Novosibirsk residents
by: A. A. Karaseva, et al.
Published: (2022-09-01)

Comparison of the effect of the alcoholic extract of leaves and fruits of hawthorn plant Crataegus azarolus with the drug simvastatin in its effect in reducing cardiovascular disease in male rabbits with experimental fat disorder
by: Muhanned H. Mukhlif Al-Obaidy, et al.
Published: (2018-08-01)

Relationship of obesity, low-density lipoprotein cholesterol and myocardial perfusion in patients with risk factors and without atherosclerotic cardiovascular diseases
by: V. B. Sergienko, et al.
Published: (2021-03-01)

2016 ESC/EAS GUIDELINES FOR THE MANAGEMENT OF DYSLIPIDAEMIAS
by: Alberico L. Catapano, et al.
Published: (2017-06-01)

RUSSIAN GUIDELINES ON FAMILIAL HYPERCHOLESTEROLEMIA DIAGNOSIS AND TREATMENT
by: article Editorial
Published: (2017-06-01)

RATIONAL APPROACHES TO THE TREATMENT OF DYSLIPIDEMIA WITH DIFFERENT TOTAL CARDIOVASCULAR RISK AND ACUTE CORONARY SYNDROME
by: N. V. Perova, et al.
Published: (2015-09-01)

Persistent dyslipidemia in statin-treated patients: Russian real-world clinical practice data (Russian part of the DYSIS Study)
by: R. G. Oganov, et al.
Published: (2012-08-01)

Linking Lipid Profile to Stress Urinary Incontinence in US Women: A National Cross-Sectional Study
by: Lu M, et al.
Published: (2025-06-01)

Metabolic Dysfunction-Associated Steatotic Liver Disease: From a Very Low-Density Lipoprotein Perspective
by: Yan Chen, et al.
Published: (2025-07-01)

PROATHEROGENIC LIPID AND LIPOPROTEIN METABOLIC DISTURBANCES IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: E. V. Gerasimova, et al.
Published: (2017-07-01)

Metabolic, Inflammatory and Imaging Biomarkers in Evaluation of Coronary Arteries Anatomical Stenosis in Patients with Stable Coronary Artery Disease
by: O. A. Koshelskaya, et al.
Published: (2020-03-01)

High Density Lipoproteins: Metabolism, Biological Functions and Risk of cardiovascular pathology
by: N. N. Smirnova, et al.
Published: (2023-12-01)

Beyond LDL-C: discordant small dense LDL cholesterol stratifies hypertension risk in a Chinese longitudinal cohort
by: Xiaofei Wu, et al.
Published: (2025-06-01)

Lipid profile in hospitalized patients with COVID-19 depending on the outcome of its acute phase: data from the international registry "Dynamics analysis of comorbidities in SARS-CoV-2 infection survivors"
by: G. P. Arutyunov, et al.
Published: (2022-09-01)

Addressing Dyslipidaemia in Advanced CKD: Insights from a Secondary Care Cohort
by: Tom Siby, et al.
Published: (2025-05-01)

VARIABILITY IN LEVELS OF LOW-DENSITY LIPOPROTEINS CHOLESTEROL IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA DEPENDING ON AGE AND SEX AND ITS IMPORTANCE IN THE DIAGNOSIS OF THIS DISEASE
by: V. А. Korneva, et al.
Published: (2017-03-01)

The impact of clinical decision support systems on adherence to clinical guidelines and achieving target levels of low-density lipoprotein cholesterol in patients at risk of developing cardiovascular events (SuccESS)
by: K. S. Astrakova (Benimetskaya), et al.
Published: (2025-01-01)

EURASIAN ASSOCIATION OF CARDIOLOGY (EAC)/ RUSSIAN NATIONAL ATHEROSCLEROSIS SOCIETY (RNAS, RUSSIA) GUIDELINES FOR THE DIAGNOSIS AND CORRECTION OF DYSLIPIDEMIA FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROSIS (2020)
by: V. V. Kukharchuk, et al.
Published: (2020-06-01)

An addition to pharmacological correction of carbohydrate and lipid metabolism in patients with metabolic syndrome
by: V. V. Skvortsov, et al.
Published: (2023-01-01)

Contradictions in traditional ideas about atherosclerosis and the efficacy of lipid-lowering therapy. Promising directions
by: A. P. Vasiliev, et al.
Published: (2024-08-01)

EFFICACY OF ROSUVASTATIN IN DYSLIPIDEMIA CORRECTION IN PATIENTS AFTER Q-WAVE MYOCARDIAL INFARCTION
by: R. D. Kurbanov, et al.
Published: (2015-09-01)

Impairment of the Lipid Metabolism in Newborns in the Early Neonatal Period
by: S. A. Perepelitsa
Published: (2018-05-01)

Uptake of cholesterol esters being a part of the different fractions of blood plasma lipoproteins by rats organs and tissues
by: L. M. Polyakov, et al.
Published: (2020-01-01)

Familial hypercholesterolemia: current status of the problem, treatment, and prevention
by: S. A. Bliznyuk, et al.
Published: (2020-11-01)

Studying Myostatin as a Diagnostic Indicator in Sera of Iraqi Women with Metabolic Syndrome
by: Riyam Hussein Assaf, et al.
Published: (2024-05-01)

CENTRALISED SURVEY ON THE UNDERTREATMENT OF THE HYPERCHOLESTEROLEMIA IN RUSSIA (CEPHEUS)
by: S. A. Boytsov, et al.
Published: (2013-08-01)

The era of targeted therapy for hyperlipidemia
by: U. V. Chubykina, et al.
Published: (2024-10-01)

Statin therapy and atherosclerosis regression
by: A. V. Susekov
Published: (1970-01-01)

Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and Sarcopenic obesity in U.S. adults: a cross-sectional study
by: Jiao Liu, et al.
Published: (2025-08-01)

The impact of a clinical decision support service on adherence to clinical guidelines and achieving target low-density lipoprotein cholesterol levels in patients at risk of cardiovascular events in the Kemerovo Oblast (SuccESS Study in the Kemerovo Oblast)
by: M. V. Ezhov, et al.
Published: (2025-07-01)

EFFECT OF SIMVASTATIN ON MARKERS OF CARDIOVASCULAR RISK
by: N. V. Perova, et al.
Published: (2016-01-01)

Bempedoic Acid: Safety and Efficiacy of a New Lipid-Lowering Agent
by: I. A. Mazerkina, et al.
Published: (2023-09-01)

Outpatient monitoring of patients with lipoprotein metabolism disorders and other lipidemias by a general practitioner in primary care. Guidelines
by: O. M. Drapkina, et al.
Published: (2025-02-01)

Randomized «FARVATER» study. Atorvastatin (10 and 20 mg/d) in treating patients with coronary heart disease and dyslipidemia: effects on lipids, C-reactive protein and fibrinogen levels
by: A. V. Susekov, et al.
Published: (2006-12-01)

Serum albumin combined with high-density lipoprotein cholesterol as a novel marker to predict coronary heart disease: are their associations multiplicative or rateable?
by: Li He, et al.
Published: (2025-07-01)